Actions
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
4
Neutral
1
Bullish
9
Bearish
36
Neutral
1
Bullish
9
Bearish
32
Neutral
0
Bullish
0
Bearish
4
Neutral
1
Bullish
9
Bearish
4
Neutral
1
Bullish
9
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Pharmaceuticals & Biotechnology
Pharmaceuticals
166 Cr
Moderate Risk
27.1
34.8
0.8
1.2
60.95
28.81
Sales CAGR
Profit CAGR
ROE
ROCE
Upcoming Result Date: Oct 26, 2026
Investor Presentation
Q3 FY26
Investor Presentation
Q4 FY25
Investor Presentation
Q4 FY23
Investor Presentation
Q2 FY23
Investor Presentation
Q1 FY23
Syschem (India) Ltd (SYSCHEM) is currently trading at 31.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Syschem India Limited manufactures active pharmaceutical ingredients (APIs) and intermediates from its Haryana manufacturing complex, having transitioned from agrochemicals to a pharmaceutical focus since FY2017–18 with a product history including 7‑ADCA and several API intermediates. The latest investor deck reports revenue moderation versus the prior quarter, with EBITDA and PBT pressured by forex volatility and softer customer demand; management emphasises disciplined cost control and production planning to maintain operational efficiency and cash flow stability. Strategically significant investments are underway to add dedicated Amoxicillin and penicillin‑class plants (Cloxacillin, Flucloxacillin, Dicloxacillin), accompanied by an explicit push for WHO‑GMP certification, indicating an effort to move up the regulated global supply chain and expand export opportunities. ESG and compliance are prominent priorities: initiatives highlighted include Zero Liquid Discharge (ZLD), carbon footprint reduction, eco‑friendly packaging, gender diversity and governance focus, reflecting management intent to meet stricter environmental and regulatory norms demanded by pharmaceutical customers. Geographic and workforce expansion are cited as growth enablers, with the company reporting broader domestic and selective international market reach and increased hiring of experienced professionals to support regulated manufacturing and quality systems.
Over the past 52 weeks, Syschem (India) Ltd has traded between a low of ₹28.81 and a high of ₹60.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Syschem (India) Ltd has a market capitalization of approximately 166.37. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Syschem (India) Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 27.10 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 166.37 Cr, Syschem (India) Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Syschem (India) Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Syschem (India) Ltd is 27.10. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
